Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: Tumor response and long term survival

This publication has 10 references indexed in Scilit:

• Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
  Journal of Clinical Oncology, 1985
• Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescue
  Cancer, 1982
• Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy
  Cancer Chemotherapy and Pharmacology, 1982
• Lipophilin-induced experimental allergic encephalomyelitis in guinea pigs
  Journal of Neuroscience Research, 1982
• PHASE-II TRIAL OF CISPLATIN IN SMALL CELL-CARCINOMA OF THE LUNG
  1981
• Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives
  Biochimie, 1978
• Chemotherapy of small cell carcinoma of the lung with V. P. 16–213
  Cancer, 1978
• VP-16-213 MONOTHERAPY FOR REMISSION INDUCTION OF SMALL CELL LUNG-CANCER - RANDOMIZED TRIAL USING 3 DOSAGE SCHEDULES
  1978
• Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)
  Cancer, 1977